OncoTherics signs collaboration agreement with University of Cambridge

OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models.

The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer.

OncoTherics signs collaboration agreement with University Health Network, Toronto

OncoTherics has signed a collaboration agreement with cancer researchers at the University Health Network, Toronto.

The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer.